Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphoma
Objective
To explore the role and outcomes using hematopoietic cell transplantation (HCT) as a treatment option with aggressive, follicular, mantle, T-cell, and HIV related non-Hodgkin’s lymphoma (NHL).
Data Sources
Research and review articles and textbooks.
Conclusion
High-dose chemotherapy and/or radiation therapy followed by HCT has been used to overcome resistance to standard-dose therapy and has been explored over the past 40 years and has shown long-term survival of approximately 10% to 50% in patients with relapsed or refractory lymphoma.
Implications for Nursing Practice
Nursing plays a significant role in the assessment and management of patients throughout the course of HCT.
Department of Clinical Practice and Professional Education, City of Hope National Medical Center, Duarte, CA
Address correspondence to Sharon K. Steingass, RN, MSN, AOCN®, Clinical Practice and Professional Education, City of Hope National Medical Center, 1500 E. Duarte Rd, Duarte, CA 91010
ABSTRACT